Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 19, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acrivon Therapeutics, Inc.
| -558.00 |
$7.69 | -$4,291.02 | -1.41% | 39.15K |
Jul 17
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Acrivon Therapeutics, Inc.
| 10K |
$1.04 | $10,400.00 | +16.92% | 69.1K |
May 17
| |||||||
Acrivon Therapeutics, Inc.
| -99.00 |
$8.36 | -$827.64 | -2.05% | 4.73K |
May 14
| |||||||
Acrivon Therapeutics, Inc.
| -184.00 |
$8.36 | -$1,538.24 | -0.46% | 39.71K |
May 14
| |||||||
Acrivon Therapeutics, Inc.
| -490.00 |
$8.36 | -$4,096.40 | -0.15% | 317.74K |
May 14
| |||||||
Acrivon Therapeutics, Inc.
| -368.00 |
$8.36 | -$3,076.48 | -1.33% | 27.26K |
May 14
| |||||||
Acrivon Therapeutics, Inc.
| -402.00 |
$8.36 | -$3,360.72 | -2.21% | 17.77K |
May 14
| |||||||
Acrivon Therapeutics, Inc.
| -613.00 |
$8.36 | -$5,124.68 | -1.03% | 59.1K |
May 14
| |||||||
Acrivon Therapeutics, Inc.
| -54.92K |
$8.36 | -$459,114.48 | -2.10% | 2.56M |
May 14
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Acrivon Therapeutics, Inc.
| -558.00 |
$10.34 | -$5,769.72 | -1.38% | 39.89K |
Apr 17
| |||||||
Acrivon Therapeutics, Inc.
| 3.53M |
$8.50 | $30,005,000.00 | +80.52% | 7.91M |
Apr 11
| |||||||
Acrivon Therapeutics, Inc.
| 2.35M |
$8.50 | $20,000,500.00 | +78.23% | 5.36M |
Apr 11
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 4
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Acrivon Therapeutics, Inc.
| -217.00 |
$3.40 | -$737.80 | -0.53% | 40.45K |
Feb 14
| |||||||
Acrivon Therapeutics, Inc.
| -579.00 |
$3.40 | -$1,968.60 | -0.18% | 318.23K |
Feb 14
| |||||||
Acrivon Therapeutics, Inc.
| -434.00 |
$3.40 | -$1,475.60 | -1.55% | 27.63K |
Feb 14
| |||||||
Acrivon Therapeutics, Inc.
| -468.00 |
$3.40 | -$1,591.20 | -2.51% | 18.17K |
Feb 14
| |||||||
Acrivon Therapeutics, Inc.
| -723.00 |
$3.40 | -$2,458.20 | -1.20% | 59.71K |
Feb 14
| |||||||
Acrivon Therapeutics, Inc.
| -41.86K |
$3.40 | -$142,327.40 | -1.57% | 2.62M |
Feb 14
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 8
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Acrivon Therapeutics, Inc.
| -652.00 |
$4.35 | -$2,836.20 | -1.58% | 40.67K |
Jan 17
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 11
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Acrivon Therapeutics, Inc.
| -735.00 |
$5.08 | -$3,733.80 | -1.75% | 41.32K |
Nov 14
| |||||||
Acrivon Therapeutics, Inc.
| -1.90K |
$5.08 | -$9,652.00 | -0.59% | 318.81K |
Nov 14
| |||||||
Acrivon Therapeutics, Inc.
| -1.47K |
$5.08 | -$7,467.60 | -4.98% | 28.06K |
Nov 14
| |||||||
Acrivon Therapeutics, Inc.
| -1.40K |
$5.08 | -$7,086.60 | -6.96% | 18.64K |
Nov 14
| |||||||
Acrivon Therapeutics, Inc.
| -2.45K |
$5.08 | -$12,446.00 | -3.90% | 60.43K |
Nov 14
| |||||||
Acrivon Therapeutics, Inc.
| -239.02K |
$5.08 | -$1,214,236.84 | -8.25% | 2.66M |
Nov 14
| |||||||
Acrivon Therapeutics, Inc.
| -2.23K |
$5.48 | -$12,231.36 | -5.04% | 42.05K |
Oct 17
| |||||||
Acrivon Therapeutics, Inc.
| 3.86K |
—
|
—
| +9.54% | 44.29K |
Sep 26
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.